Journal article

Vascular Response of the Segments Adjacent to the Proximal and Distal Edges of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold: 6-Month and 1-Year Follow-Up Assessment A Virtual Histology Intravascular Ultrasound Study From the First-in-Man ABSORB Cohort B Trial

Bill D Gogas, Patrick W Serruys, Roberto Diletti, Vasim Farooq, Salvatore Brugaletta, Maria D Radu, Jung Ho Heo, Yoshinobu Onuma, Robert-Jan M van Geuns, Evelyn Regar, Bernard De Bruyne, Bernard Chevalier, Leif Thuesen, Pieter C Smits, Dariusz Dudek, Jacques Koolen, Stefan Windecker, Robert Whitbourn, Karine Miquel-Hebert, Cecile Dorange Show all

JACC Cardiovascular Interventions | ELSEVIER SCIENCE INC | Published : 2012


Funding Acknowledgements

From the *Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands; dagger Cardiovascular Center, Aalst, Belgium; double dagger Institut Jacques Cartier, Massy, France; Skejby Sygehus, Aarhus University Hospital, Aarhus, Denmark; parallel to Maasstad Hospital, Rotterdam, the Netherlands; Jagiellonian University, Krakow, Poland; #Catharina Hospital, Eindhoven, the Netherlands; **Bern University Hospital, Bern, Switzerland; dagger dagger St. Vincent's Hospital, Fitzroy, Australia; double dagger double dagger Abbott Vascular, Diegem, Belgium; Abbott Vascular, Santa Clara, California; parallel to parallel to Cardialysis, Rotterdam, the Netherlands; Christchurch Hospital, Christchurch, New Zealand; and the ##Auckland City Hospital, Auckland, New Zealand. Dr. Gogas wishes to acknowledge the American College of Cardiology Foundation for the International Society of Cardiovascular Translational Research Award, and Hellenic Cardiological Society and Hellenic Heart Foundation for providing funding support. Dr. Chevalier is a consultant for Abbott Vascular. Prof. Dudek has received research grants or served as consultant/advisory board member for Abbott, Adamed, AstraZeneca, Biotronik, Balton, Bayer, BBraun, BioMatrix, Boston Scientific, Boehringer-Ingelheim, Bristol-Myers Squibb, Cordis, Cook, Eli Lilly & Co., EuroCor, GlaxoSmithKline, Invatec, Medtronic, The Medicines Company, MSD, Nycomed, Orbus-Neich, Pfizer, Possis, Promed, Sanofi-Aventis, Siemens, Solvay, Terumo, and Tyco. Dr. Windecker received research grants to the institution from Abbott, Biotronik, Biosensors, Boston Scientific, and Cordis. Dr. Ormiston was on the advisory board of and received minor honoraria from Abbott Vascular and Boston Scientific. Drs. Miquel-Hebert and Rapoza and Ms. Dorange are employees of Abbott Vascular. Michael Kutcher, MD, served as Guest Editor for this paper. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.